Terai Kazuhiro, Mizukami Kazuhiko, Okada Masamichi
Kidney and Digestive Tracts Laboratory, Institute of Pharmacology, Astellas Pharma Co. Ltd, Miyukigaoka, Tsukuba, Ibaraki, Japan.
Nephrology (Carlton). 2008 Apr;13(2):139-46. doi: 10.1111/j.1440-1797.2007.00844.x.
Several animal models with chronic renal failure have been established and used for demonstrating complications including hyperphosphataemia. Although long-time feeding is required to cause hyperphosphataemia in animals, a few modifications have been reported to provide more useful models for research.
Three separate experiments were carried out in the present study. First, characteristics of commonly used subnephrectomized (5/6Nx) rats and rats fed an adenine diet (0.75% adenine in normal diet) were compared as hyperphosphataemia models. Next, using adenine-diet rats, the inhibitory effect of sevelamer hydrochloride (Sev) on serum phosphorus elevation was examined. Third, oral adenine dosing for induction of hyperphosphataemia and validation as a model using Sev were examined.
Serum phosphorus in 5/6Nx rats became elevated in 8-17 weeks, but the levels and time points of elevation differed among animals. In adenine-fed rats, the elevation was more clearly demonstrated with less diversity at 4 weeks. The data revealed a potential shorter model preparation period and the importance of controlling feeding amounts. Oral adenine dosing induced hyperphosphataemia by 12 days, and Sev treatment was inhibitory. After a maintenance period of over a month (no treatments), Sev-treated rats showed hyperphosphataemia as did oral adenine-dosed control rats. The serum phosphorus levels significantly decreased on further Sev treatment.
Oral dosing with adenine made the model preparation period definitely shorter, and its usefulness as a hyperphosphataemia model was revealed using Sev.
已经建立了几种慢性肾衰竭动物模型,并用于证明包括高磷血症在内的并发症。尽管在动物中需要长时间喂食才能导致高磷血症,但据报道一些改进方法可提供更有用的研究模型。
本研究进行了三项独立实验。首先,比较常用的肾次全切除(5/6Nx)大鼠和喂食腺嘌呤饮食(正常饮食中含0.75%腺嘌呤)的大鼠作为高磷血症模型的特征。其次,使用喂食腺嘌呤饮食的大鼠,研究盐酸司维拉姆(Sev)对血清磷升高的抑制作用。第三,研究口服腺嘌呤诱导高磷血症并验证其作为使用Sev的模型的有效性。
5/6Nx大鼠的血清磷在8 - 17周时升高,但升高水平和时间点在动物之间有所不同。在喂食腺嘌呤的大鼠中,4周时升高更明显,且差异较小。数据显示模型制备期可能更短以及控制喂食量的重要性。口服腺嘌呤给药12天后诱导出高磷血症,Sev治疗具有抑制作用。经过一个多月的维持期(无治疗)后,接受Sev治疗的大鼠与口服腺嘌呤给药的对照大鼠一样出现高磷血症。进一步进行Sev治疗后,血清磷水平显著下降。
口服腺嘌呤使模型制备期明显缩短,并且使用Sev揭示了其作为高磷血症模型的有效性。